Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Pfizer LeadsR&D Spending

October 22, 2007 | A version of this story appeared in Volume 85, Issue 43

Of the 2,000 companies compared by the European Commission in its annual scorecard for global industrial R&D investment, Pfizer spent the most last year. Pfizer sank $7.6 billion into research in 2006, overtaking Ford Motor Co. as the number-one spender. Pharmaceuticals and biotechnology emerged as the leading R&D investing sector, surpassing the technology hardware and equipment sector. Meanwhile, the chemicals sector bounced back with 9.8% growth in R&D investment in 2006, following a decline in 2005. Overall investment by the companies tracked by the scoreboard totaled $467 billion, a 10% increase. And R&D investment by European companies continues to lag that of the U.S.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.